244 related articles for article (PubMed ID: 32156761)
1. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study.
Plym A; Clements M; Voss M; Holmberg L; Stattin P; Lambe M
BMJ Open; 2020 Mar; 10(3):e032914. PubMed ID: 32156761
[TBL] [Abstract][Full Text] [Related]
2. Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study.
Plym A; Chiesa F; Voss M; Holmberg L; Johansson E; Stattin P; Lambe M
Eur Urol; 2016 Jul; 70(1):64-71. PubMed ID: 26782345
[TBL] [Abstract][Full Text] [Related]
3. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.
Lane JA; Donovan JL; Davis M; Walsh E; Dedman D; Down L; Turner EL; Mason MD; Metcalfe C; Peters TJ; Martin RM; Neal DE; Hamdy FC;
Lancet Oncol; 2014 Sep; 15(10):1109-18. PubMed ID: 25163905
[TBL] [Abstract][Full Text] [Related]
4. Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age.
Plym A; Johansson ALV; Bower H; Voss M; Holmberg L; Fredriksson I; Lambe M
Breast; 2019 Jun; 45():48-55. PubMed ID: 30852409
[TBL] [Abstract][Full Text] [Related]
5. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.
Thomsen FB; Røder MA; Jakobsen H; Langkilde NC; Borre M; Jakobsen EB; Frey A; Lund L; Lunden D; Dahl C; Brasso K
Clin Genitourin Cancer; 2019 Aug; 17(4):e814-e821. PubMed ID: 31196798
[TBL] [Abstract][Full Text] [Related]
6. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance.
Godtman RA; Schafferer M; Pihl CG; Stranne J; Hugosson J
J Urol; 2018 Oct; 200(4):779-785. PubMed ID: 29730198
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for disability pension in a population-based cohort of men and women on long-term sick leave in Sweden.
Karlsson NE; Carstensen JM; Gjesdal S; Alexanderson KA
Eur J Public Health; 2008 Jun; 18(3):224-31. PubMed ID: 18245150
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer.
Lao C; Edlin R; Rouse P; Brown C; Holmes M; Gilling P; Lawrenson R
BMC Cancer; 2017 Aug; 17(1):529. PubMed ID: 28789623
[TBL] [Abstract][Full Text] [Related]
10. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
[TBL] [Abstract][Full Text] [Related]
11. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
12. Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Neal DE; Metcalfe C; Donovan JL; Lane JA; Davis M; Young GJ; Dutton SJ; Walsh EI; Martin RM; Peters TJ; Turner EL; Mason M; Bryant R; Bollina P; Catto J; Doherty A; Gillatt D; Gnanapragasam V; Holding P; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Altman DG; Hamdy FC;
Eur Urol; 2020 Mar; 77(3):320-330. PubMed ID: 31771797
[TBL] [Abstract][Full Text] [Related]
13. Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study.
Plym A; Johansson ALV; Bower H; Wennstig AK; Fredriksson I; Ahlgren J; Lambe M
Breast Cancer Res Treat; 2020 Aug; 182(3):699-707. PubMed ID: 32506337
[TBL] [Abstract][Full Text] [Related]
14. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
15. Open retropubic prostatectomy versus robot-assisted laparoscopic prostatectomy: a comparison of length of sick leave.
Hohwü L; Akre O; Pedersen KV; Jonsson M; Nielsen CV; Gustafsson O
Scand J Urol Nephrol; 2009; 43(4):259-64. PubMed ID: 19353381
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis-specific sick leave as a risk marker for disability pension in a Swedish population.
Kivimäki M; Ferrie JE; Hagberg J; Head J; Westerlund H; Vahtera J; Alexanderson K
J Epidemiol Community Health; 2007 Oct; 61(10):915-20. PubMed ID: 17873230
[TBL] [Abstract][Full Text] [Related]
17. Sick-leave track record and other potential predictors of a disability pension. A population based study of 8,218 men and women followed for 16 years.
Wallman T; Wedel H; Palmer E; Rosengren A; Johansson S; Eriksson H; Svärdsudd K
BMC Public Health; 2009 Apr; 9():104. PubMed ID: 19368715
[TBL] [Abstract][Full Text] [Related]
18. Is there an association between long-term sick leave and disability pension and unemployment beyond the effect of health status?--a cohort study.
Hultin H; Lindholm C; Möller J
PLoS One; 2012; 7(4):e35614. PubMed ID: 22558176
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study.
Robinson D; Garmo H; Lissbrant IF; Widmark A; Pettersson A; Gunnlaugsson A; Adolfsson J; Bratt O; Nilsson P; Stattin P
Eur Urol; 2018 Apr; 73(4):502-511. PubMed ID: 29254629
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study.
Thomsen FB; Garmo H; Brasso K; Egevad L; Stattin P
J Surg Oncol; 2021 Oct; 124(5):867-875. PubMed ID: 34145588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
